PTEN and metastatic malignant neoplasm in the lymph nodes: The pooled results suggested that PTEN loss was significantly associated with the presence of lymph node metastasis (pooled OR = 0.61, 95% CI = 0.45–0.82, P = 0.0001 using a random-effects model; Figure 3B).